Clinical Trial: Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Interventional
Official Title: Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma
Brief Summary: The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.
Detailed Summary:
Sponsor: Sun Yat-sen University
Current Primary Outcome:
- quality of life [ Time Frame: 1,3,5,10 year. ]
- pregnant [ Time Frame: 3 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- tumor recurrence [ Time Frame: 1,3,5,10 years ]
- complications [ Time Frame: 3,6,12,24 months ]
- ovarian functions [ Time Frame: 3,6,12 months, 2,3,5 and 10 years ]
- symptom relief [ Time Frame: 3,6,12,24 months ]
- tumour volume [ Time Frame: 3,6,12 18 24 months and 3,5,10 years ]
Original Secondary Outcome: Same as current
Information By: Sun Yat-sen University
Dates:
Date Received: January 9, 2009
Date Started: January 2008
Date Completion: December 2018
Last Updated: January 9, 2009
Last Verified: January 2009